Actual - Legal

The dependent visa is a non-immigrant dependent visa for dependents of F-1 visa
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
> or student visaholders. A spouse and unmarried, minor children may also apply for anon-immigr
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in
ant visa to accompany the student. Family members must meet all visa eligibility requirements, including evidenc
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

e that the student will have sufficient funds for the studies as well as supporting the dependents. They must al
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
so present convincing evidence that the dependents will depart the country when the student's program ends. Spou
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro
ses and children of students may not accept employment at any time, but they are allowed to study in the country
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
using the dependent visas.

The spouse and children may either come with the student or come l
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ater to that country on dependents visa status. Dependents should go with the student to the em
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
bassy or consulate where they apply for the student visa.It is also possible to apply later for the F-2 visa or
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
dependent visabased on the F-1 visa or student visa status. It is always bette
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
r to apply together for the student and dependents visas so that all the documents can be verified at one time.
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

The student must establish his or her relationship with the dependents by showing documents such as birth or ma
dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod
rriage certificates. If the student's spouse or children are following to join at a later date, then he or she s
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
hould provide the U.S. embassy staff with a copy of the USCIS Form I-20 ID(Certificate of Eligibility for Non-im
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
migrant (F-1) Student Status - for academic and Language Students) and proof of their relationship with the stud
t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ent. The F-2 or dependent status will be dependent upon the status as theF-1 or student visa. This means that an
ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust
y change in the student's status will affect his or her dependent.

If the student loses his or her status, then
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
all of the dependents will also lose their status.
The spouse and minor children of participants in J exchan
.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ge programs may apply for J-2 visas to accompany the student by presenting a copy of the student's form DS-2019.
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip
They must demonstrate that they will have sufficient financial resources to cover all expenses while in the U.S

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Actual - Dependents Visa

Related Articles: